Coyote Ventures is a San Francisco-based venture capital firm that specializes in early-stage investments in women's health and wellness startups. The firm typically participates in pre-seed, seed, and Series A funding rounds, supporting companies that are pioneering advancements in this niche sector. Founded in 2021 by Jessica Karr and Dr. Brittany Barreto, Coyote Ventures aims to drive innovation and growth in businesses that address critical aspects of women's health.
Notable portfolio companies include Betterleave, Hera Biotech, Malama Health, Maude, and Wile, with investments ranging from $1.5 million to $5.8 million. The firm's key partners bring a wealth of experience and a strong network to the table, enhancing their ability to support portfolio companies. Jessica Karr and Dr. Brittany Barreto leverage their backgrounds to provide strategic guidance and unique value-add services, such as industry-specific mentorship and access to a robust network of healthcare professionals and investors.
Coyote Ventures - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies5
Current Portfolio Count5
Top Investment Stages
Seed3 (60.0%)
Pre-Seed1 (20.0%)
Series A1 (20.0%)
Stage Mix
Seed 60%Pre-Seed 20%Series A 20%
Concentration shown as share of disclosed investments by stage.